Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B

BACKGROUND/AIMS: Renal toxicity is a concern in patients with chronic hepatitis B taking nucleotide analogues, such as adefovir (ADV) and tenofovir disoproxil fumarate (TDF). We sought to determine the long-term renal effects of nucleotide analogue treatment versus entecavir (ETV) treatment. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Young Youn, Chang, Young, Nam, Joon Yeul, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096224/
https://www.ncbi.nlm.nih.gov/pubmed/31060115
http://dx.doi.org/10.5009/gnl18474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096224/
https://www.ncbi.nlm.nih.gov/pubmed/31060115
http://dx.doi.org/10.5009/gnl18474

Ejemplares similares